Figure 7. The schematic representation of anti-metastasis effects of zoledronate in human osteosarcoma U2OS cells.
Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cell-matrix and cell-cell interactions, migration potential, the invasive activity, and the adhesive ability by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.